EMEA-002033-PIP01-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Vosoritide (BMN 111)

Decision numberP/0379/2017
PIP numberEMEA-002033-PIP01-16
Pharmaceutical form(s)Powder for solution for injection
Condition(s)/indication(s)

Treatment of achondroplasia

Route(s) of administrationSubcutaneous use
PIP applicant

BioMarin International Limited
Tel. +44 2074200800
E-mail: biomarin-europe@bmrn.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision